Blood plasma proteomic markers of Alzheimer’s disease, current status and application prospects
Expert Review of Proteomics,
Journal Year:
2025,
Volume and Issue:
22(1), P. 11 - 18
Published: Jan. 2, 2025
Introduction
Identifying
early
risks
of
developing
Alzheimer's
disease
(AD)
is
a
major
challenge
as
the
number
patients
with
AD
steadily
increases
and
requires
innovative
solutions.
Current
molecular
diagnostic
modalities,
such
cerebrospinal
fluid
(CSF)
testing
positron
emission
tomography
(PET)
imaging,
exhibit
limitations
in
their
applicability
for
large-scale
screening.
In
recent
years,
there
has
been
marked
shift
toward
development
blood
plasma-based
tests,
which
offer
more
accessible
clinically
viable
alternative
widespread
use.
Furthermore,
advances
proteomics
technologies
have
boosted
an
interest
identifying
novel
biomarkers
panels
AD-associated
proteins.
Language: Английский
Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke
Journal of Proteome Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 3, 2025
The
immune
response
plays
a
crucial
role
in
the
treatment
of
ischemic
stroke
(IS).
Our
primary
objective
was
to
explore
proteins
related
and
develop
noninvasive
diagnostic
panel.
We
used
high-throughput
Olink
immunoassay
platform
quantitatively
measure
92
serum
88
patients
with
IS
controls.
first
selected
feature
using
least
absolute
shrinkage
selection
operator
(LASSO),
random
forest
(RF),
support
vector
machine
(SVM),
then
modeled
them
for
external
validation
IS.
In
this
study,
we
found
that
53
exhibited
significant
differences
compared
control
group.
GLB1,
PRDX5,
DDX58,
CLEC4C
as
potential
protein
biomarkers
differentiate
from
group
LASSO,
RF,
SVM.
model,
which
included
these
four
proteins,
demonstrated
excellent
performance
data
sets,
achieving
an
AUC
value
0.899
(95%CI:
0.848-0.950).
findings
offer
valuable
insights
into
both
diagnosis
These
results
novel
approach
clinical
decision-making
Language: Английский
Distinct Alterations of Inflammatory Biomarkers in Cluster Headache: A Case Control Study
Annals of Neurology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 21, 2025
Objective
Investigate
the
immune
system's
role
in
cluster
headache
by
analyzing
cytokines
people
with
and
headache‐free
controls,
explore
if
certain
could
predict
a
specific
phenotype.
Methods
We
measured
45
adult
participants
from
Danish
Cluster
Headache
Biobank
prospective
case–control
setup.
People
were
diagnosed
according
to
International
Classification
of
Disorders
third‐edition.
Controls
matched
for
age
sex.
Results
A
total
412
analyzed
deriving
99
chronic
headache,
108
episodic
(ECH)
bout,
105
ECH
remission,
100
successfully
controls.
Compared
13
altered
bout
(
p
<
0.05),
3
remission
10
0.05).
Oncostatin
m
was
significantly
elevated
all
disease
states
compared
controls
Overall,
investigated
showed
distinct
patterns
alterations
between
and,
interestingly,
IL‐1β
associated
having
rather
than
logistic
regression
model
adjusting
potential
confounders
Interpretation
Findings
show
that
system
is
elevated,
constituting
promising
target
future
studies.
The
are
striking
urges
further
research
better
understand
its
prediction
activity
treatment
response.
ANN
NEUROL
2025
Language: Английский
Computational tools in genomics and proteomics
Sharav Desai,
No information about this author
Vipul Patel,
No information about this author
Kunal Bhosle
No information about this author
et al.
Elsevier eBooks,
Journal Year:
2025,
Volume and Issue:
unknown, P. 489 - 518
Published: Jan. 1, 2025
Language: Английский
Pemphigoid disease model systems for clinical translation
Michael Tigges,
No information about this author
Sören Dräger,
No information about this author
Ilaria Piccini
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 17, 2025
Pemphigoid
diseases
constitute
a
group
of
organ-specific
autoimmune
characterized
and
caused
by
autoantibodies
targeting
autoantigens
expressed
in
the
skin
mucous
membranes.
Current
therapeutic
options
are
still
based
on
unspecific
immunosuppression
that
is
associated
with
severe
adverse
events.
Biologics,
IL4-pathway
or
IgE
expected
to
change
treatment
landscape
pemphigoid
diseases.
However,
clinical
studies
demonstrated
these
pathways
alone
most
likely
not
sufficient
meet
patient
healthcare
partitioners
expectations.
Hence,
model
systems
needed
identify
validate
novel
targets
These
include
pre-clinical
animal
models,
vitro
ex
vivo
systems,
hypothesis-driven
drug
repurposing,
as
well
exploitation
real-world-data.
In
this
review,
we
will
highlight
medical
need
for
diseases,
in-depth
discuss
advantages
disadvantages
available
disease
systems.
Ultimately,
how
rapid
translation
can
be
achieved
benefit
patients.
Language: Английский
The Association of Serum Biomarkers With Symptomatic Hemorrhagic Transformation in Acute Ischemic Stroke Patients: A Combined Retrospective and Prospective Study
CNS Neuroscience & Therapeutics,
Journal Year:
2025,
Volume and Issue:
31(3)
Published: March 1, 2025
Symptomatic
intracranial
hemorrhage
transformation
(s-HT)
is
a
serious
complication
of
ischemic
stroke,
leading
to
early
neurological
deterioration
and
poor
prognosis.
It
an
urgent
problem
timely
effectively
identify
high-risk
patients
with
s-HT
at
the
stage
stroke.
However,
so
far,
there
are
no
effective
clinical
detection
methods
or
measures.
Therefore,
present
study
aimed
explore
novel
blood
biomarkers
related
s-HT.
This
includes
two
parts:
retrospective
prospective
cohort
study.
In
first
part,
were
screened
(n
=
18),
non-s-HTs
128)
selected
from
same
period
case
in
cohort.
The
baseline
samples
obtained
within
30
min
admission,
levels
92
proteins
cerebrovascular
diseases
detected
using
Olink
proteomics
technology.
Multivariate
logistic
regression
receiver
operating
characteristic
curves
used
analyze
relationship
between
serum
biomarker
second
28)
130)
cohort,
which
met
criteria
for
inclusion
exclusion.
Enzyme-linked
immunosorbent
assay
(ELISA)
was
measure
potential
biomarker(s)
part
confirm
its/their
association(s)
showed
that
had
lower
von
Willebrand
factor
(vWF)
higher
osteoprotegerin,
phospholipase
C,
human
insulin-like
growth
binding
protein-7,
matrix
metalloproteinase-2,
galectin-4,
spondin-1
than
(p
<
0.005)
Principal
component
(PC)
analysis
seven
could
explain
62.76%
variance
set,
vWF
main
loading
PC2.
low
level
independent
risk
0.05)
after
adjusting
confounders.
ELISA
test
results
significantly
non-s-HT
group
(26.57
[13.64-37.18]
vs.
42.00
[26.02-55.52]
ng/mL,
p
0.001)
Incorporating
into
factors
improved
accuracy
predicting
(area
under
curve
[AUC,
0.731
0.641,
0.001],
0.747
0.560,
0.001])
compared
model
employing
only
both
cohorts.
Through
use
combined
study,
might
be
occurrence
stroke
patients.
Language: Английский
Seasonal Proteomic Variations and Biomarkers in Seasonal Allergic Rhinitis: Insights from Olink Inflammation Profiling
Jiaqi Shen,
No information about this author
Xinliang Zheng,
No information about this author
Mengting Yan
No information about this author
et al.
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 6191 - 6202
Published: May 1, 2025
Seasonal
allergic
rhinitis
(SAR)
is
a
prevalent
inflammatory
condition,
yet
its
molecular
mechanisms
and
reliable
biomarkers
remain
incompletely
understood.
This
study
aimed
to
identify
key
inflammation-related
proteins
pathways
associated
with
SAR
by
investigating
seasonal
proteomic
profile
variations
their
correlations
symptoms.
Serum
samples
were
collected
from
nineteen
patients
during
both
allergy
(in-season,
IS)
non-allergy
(out-of-season,
OS)
periods.
Differentially
expressed
(DEPs)
identified
using
the
Olink
Target
96
Inflammation
panel,
which
further
analyzed
through
Gene
Ontology
(GO)
Kyoto
Encyclopedia
of
Genes
Genomes
(KEGG)
pathway
enrichment
analyses.
Spearman
correlation
analysis
was
conducted
explore
associations
between
DEPs
symptoms,
including
sneezing,
rhinorrhea,
nasal
blockage,
itchy
nose,
eye.
A
total
36
identified,
all
significantly
upregulated
in
season.
Notable
such
as
glial
cell
line-derived
neurotrophic
factor
(GDNF),
interleukin-18
receptor
1
(IL-18R1),
interleukin-15
alpha
(IL-15RA)
showed
strong
Sneezing
IL-2
beta
(IL-2RB)
(r
=
0.415,
p
0.013),
rhinorrhea
FMS-related
tyrosine
kinase
3
ligand
(Flt3L)
0.455,
0.004),
blockage
osteoprotegerin
(OPG)
0.493,
0.002).
GO
revealed
enrichments
Ras
signaling
small
GTPase
pathways,
while
KEGG
highlighted
immune-related
PI3K-Akt
cytokine-cytokine
interactions.
that
vary
seasonally
SAR,
offering
insights
into
potential
therapeutic
targets
for
management.
Further
studies
are
recommended
validate
these
findings
larger
more
diverse
populations.
Language: Английский
The Role of Omics Techniques in Diabetic Wound Healing: Recent Insights into the Application of Single-Cell RNA Sequencing, Bulk RNA Sequencing, Spatial Transcriptomics, and Proteomics
Eleftheria-Angeliki Valsami,
No information about this author
Gilbert Chu,
No information about this author
Ming Guan
No information about this author
et al.
Advances in Therapy,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 17, 2025
Language: Английский
Proteomic Markers of Aging and Longevity: A Systematic Review
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(23), P. 12634 - 12634
Published: Nov. 25, 2024
This
article
provides
a
systematic
review
of
research
conducted
on
the
proteomic
composition
blood
as
part
complex
biological
age
estimation.
We
performed
comprehensive
analysis
17
publicly
available
datasets
and
compiled
an
integral
list
proteins.
These
proteins
were
sorted
based
their
detection
probability
using
mass
spectrometry
in
human
plasma.
propose
this
basis
for
creating
panel
peptides
quantifying
content
selected
format
aging
clock.
The
are
especially
notable
roles
inflammatory
processes
lipid
metabolism.
Our
findings
suggest,
first
time,
that
associated
with
systemic
disorders,
including
those
approved
by
FDA
clinical
use,
could
serve
potential
markers
aging.
Language: Английский
Early prediction of spontaneous preterm birth before 34 gestational weeks based on a combination of inflammation-associated plasma proteins
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 15, 2024
In
order
to
identify
and
possibly
offer
prophylactic
treatment
women
at
risk
for
preterm
birth
(PTB),
novel
prediction
models
PTB
are
needed.
Our
objective
was
utilize
high-sensitive
plasma
protein
profiling
investigate
whether
early
of
spontaneous
(sPTB)
before
34
gestational
weeks
(gw)
possible
in
a
low-risk
population.
A
case-control
study
conducted
on
46
with
sPTB
gw
normal
pregnancies
term
deliveries.
Prospectively
collected
sampled
11
(range
7-16)
25
23-30)
analyzed
high-sensitivity
Proximity
Extension
Assay
levels
177
inflammation-associated
proteins,
statistically
processed
multivariate
logistic
regression
analysis.
the
first
trimester,
higher
hepatocyte
growth
factor
(HGF)
were
associated
<34
(OR
1.49
(1.03-2.15)).
second
interleukin
(IL)-10
2.15
(1.18-3.92)),
IL-6
2.59
(1.34-4.99)),
receptor
activator
nuclear
κB
(RANK)
2.18
(1.26-3.77))
gw.
The
area
under
curve
including
these
proteins
0.653
(0.534-0.759)
trimester
0.854
(0.754-0.925)
trimester.
combination
from
pregnancy
showed
good
predictive
ability
regarding
gw,
suggesting
it
could
be
valuable
supplement
assessment
clinical
sPTB.
However,
although
high
number
(n=177)
method,
remains
elusive.
Language: Английский